Vascular Closure Devices Market Overview
The Vascular Closure Devices Market is growing as interventional cardiology, structural heart procedures, and endovascular interventions increasingly require reliable and efficient vascular access-site management. Rising TAVR and EVAR volumes, adoption of large-bore access devices, outpatient procedures, and advances in bioabsorbable closure technologies are supporting market expansion.
According to Market Research Future, the global Vascular Closure Devices Market was valued at USD 1.88 Billion in 2025 and is projected to grow from USD 2.00 Billion in 2026 to USD 3.69 Billion by 2035, registering a CAGR of 7.05% during 2026–2035. North America held the largest regional position with 37.4% market share in 2025, while Asia-Pacific is the fastest-growing region at a projected CAGR of 9.6%. Active Approximators accounted for 50.6% share, Interventional Cardiology represented 35.2% of procedure-linked demand, and Hospitals held 51.0% end-user share in 2025.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/5704
Key players driving innovation and competitiveness in the Vascular Closure Devices Market include:
Abbott
Terumo
Teleflex
Medtronic
Boston Scientific
Becton Dickinson
Cordis
Merit Medical Systems
Haemonetics (Cardiva)
InSeal Medical
The market is being shaped by increasing TAVR and EVAR procedures, growing adoption of large-bore femoral access, same-day discharge protocols, and technological advances in mechanical and bioabsorbable closure systems. Hospitals and catheterization labs are increasingly prioritizing predictable hemostasis, faster ambulation, and reduced operator-dependent variability.
The Vascular Closure Devices Market can be segmented by Device Type into Passive Closure Devices, Active Closure Devices, Suture Closure Devices, and Collagen-based Closure Devices. By Procedure Type, it includes Transvascular Procedures, Cardiac Procedures, and Peripheral Procedures. By End User, it covers Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. By Distribution Channel, it includes Direct Sales, Online Sales, and Third-party Distributors. By Region, it covers North America, Europe, South America, Asia-Pacific, and the Middle East & Africa.
The growing demand for efficient vascular access management is creating opportunities for medical-device manufacturers, interventional cardiology companies, hospitals, ambulatory surgical centers, and specialty vascular clinics. Fully bioabsorbable platforms, large-bore closure systems, AI-assisted device selection, cloud-based outcomes tracking, and radial-access compression technologies can support future market development.
Recent Developments and Market Trends:
Active Approximators remain the leading technology category with 50.6% revenue share in 2025, reflecting strong clinician preference for mechanical and suture-mediated closure.
Passive Approximator systems are projected to grow at a 7.5% CAGR through 2035 as bioabsorbable collagen plugs gain adoption.
Collagen-based materials accounted for approximately USD 0.88 Billion in 2025, supported by their established clinical track record.
Interventional Cardiology represented the largest procedure-linked category with 35.2% share in 2025.
Neurovascular procedures are projected to be the fastest-growing procedural segment at a 9.9% CAGR through 2035, supported by increasing endovascular stroke intervention volumes.
Femoral access sites of 8 Fr or smaller held 56.3% share in 2025, while large-bore femoral access of 12 Fr or greater is expanding rapidly alongside structural heart procedures.
Structural Heart and TAVR procedures are projected to grow at an 8.4% CAGR through 2035 as indications and procedural volumes expand.
Hospitals remain the leading end-user segment with 51.0% share because of their comprehensive procedural infrastructure and high volume of complex vascular interventions.
Catheterization Labs and Ambulatory Surgical Centers are projected to grow at a 7.8% CAGR as more lower-acuity procedures shift toward outpatient settings.
TAVR and EVAR procedural growth is creating sustained demand for closure systems capable of managing large-bore access sites.
Same-day discharge protocols are encouraging healthcare providers to adopt closure technologies that support predictable hemostasis and faster patient ambulation.
Fully resorbable closure platforms are emerging as an important opportunity for patients and clinicians seeking reduced long-term foreign-material considerations.
Large-bore closure systems designed for 22–25 Fr access are gaining importance as structural heart programs expand.
Emerging markets, particularly India and Southeast Asia, offer significant conversion opportunities as catheterization laboratory capacity grows and device-based closure adoption increases.
AI-assisted procedural planning is emerging as a future opportunity, with software designed to recommend closure-device types based on access-site anatomy and patient risk factors.
Cloud-based outcomes tracking and registry integration are creating additional service-revenue opportunities beyond traditional device sales.
Radial-access growth is encouraging innovation in compression-band technologies, creating opportunities beyond conventional femoral closure devices.
North America remains the largest regional market with 37.4% share in 2025. Asia-Pacific is the fastest-growing region at a projected CAGR of 9.6% through 2035, supported by expanding catheterization-lab infrastructure and rising interventional cardiology volumes in China and India.
Reasons to Buy the Report:
Provides comprehensive insights into the Vascular Closure Devices Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across active approximators, passive approximators, collagen-based systems, suture-based systems, and large-bore closure technologies.
Offers detailed segmentation analysis across device type, procedure type, end user, distribution channel, and geographic markets.
Includes competitive intelligence covering leading vascular closure, interventional cardiology, structural heart, and medical-device companies.
Supports informed decisions using market forecasts, TAVR and EVAR growth, large-bore access adoption, outpatient procedures, bioabsorbable materials, and regional opportunities.
Future Outlook:
The future of the Vascular Closure Devices Market will be shaped by rising structural heart procedures, large-bore vascular access, outpatient care, bioabsorbable materials, and advances in procedural automation. Active Approximators should continue to lead the device category, while Passive Approximators are positioned for steady growth. Interventional Cardiology should remain the largest procedural segment, while Neurovascular procedures are expected to grow rapidly. Hospitals should continue to dominate end use, while Catheterization Labs and Ambulatory Surgical Centers gain importance. North America should retain market leadership, while Asia-Pacific should remain the fastest-growing region. Market Research Future projects the market to reach USD 3.69 Billion by 2035 at a CAGR of 7.05%.
➤➤Explore Our Latest Related Reports:
